Athos Therapeutics, Inc.
Last verified 2026-05-21. JSON
| Total raised | $10.3M |
|---|---|
| Latest round | Funding round, $10.3M, 2026-04-17 |
| Founded | 2019 |
| Headquarters | Torrance, CA |
| Industry | pharmaceuticals |
| Stage | unknown |
| Website | athostx.com |
Pharmaceutical company
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-17 | Funding round | $10.3M | undisclosed |
Detected tech stack
LiteSpeed, PHP 8.3.28, WordPress 6.9.4, Yoast SEO 27.6, GSAP, Font Awesome, Swiper, jQuery Migrate 3.4.1, Elementor 4.0.9, cdnjs, Zepto, WPMU DEV Smush 4.0.3
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $10.3M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $10.3M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | athostx.com, read 2026-05-21 |
| Description | self-reported | athostx.com, read 2026-05-21 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $10.3M, 2026-04-17 → Funding round, $10.3M, 2026-04-17, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $10.3M, 2026-04-17 → Funding round, $10.3M, 2026-04-17 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes